Differential mononuclear cell activity and endothelial inflammation in coronary artery disease and cardiac syndrome X

International Journal of Cardiology

Volumn 89, Issue 1, 2003, Pages 53-62

  Lin, Chih Pei ^a   Lin, Wen Tsai ^a   Leu, Hsin Bang ^a,b   Wu, Tao Cheng ^a,b   Chen, Jaw Wen ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Atherosclerosis; Inflammation; Mononuclear cell; Superoxide; Syndrome X

Indexed keywords

BIOLOGICAL MARKER; CELL ADHESION MOLECULE; FREE RADICAL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INULIN; PHORBOL 13 ACETATE 12 MYRISTATE; SUPEROXIDE; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; AGED; ANALYTICAL PARAMETERS; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD ANALYSIS; CELL ACTIVATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENDOTHELIUM LESION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; SOLUBILITY; SYNDROME X;

EID: 0037408460     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(02)00428-X     Document Type: Article

References (47)

1. Vogel R.A. Coronary risk factors, endothelial function, and atherosclerosis: a review. Clin Cardiol. 20:1997;426-432.
2. Harrison D.G., Ohara Y. Physiologic consequences of increased vascular oxidant stresses in hypercholesterolemia and atherosclerosis: implications for impaired vasomotion. Am J Cardiol. 75:1995;75-81B.
3. Ikeda U., Takahashi M., Shimada K. Monocyte-endothelial cell interaction in atherogenesis and thrombosis. Clin Cardiol. 21:1998;11-18.
4. Pronai L., Hiramatsu K., Saigusa Y., et al. Low superoxide scavenging activity associated with enhanced superoxide generation by monocytes from male hypertriglyceridemia with and without diabetes. Atherosclerosis. 90:1991;39-47.
5. O'Brien K.D., McDonald T.O., Chait A., et al. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation. 93:1996;672-682.
6. Lee W.H., Lee Y., Kim J.R., et al. Activation of monocytes, T-lymphocytes and plasma inflammatory markers in angina patients. Exp Mol Med. 31:1999;159-164.
7. Aukrust P., Berge R.K., Ueland T., et al. Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes. J Am Coll Cardiol. 37:2001;485-491.
8. Dubois-Rande J.L., Artigou J.Y., Darmon J.Y., et al. Oxidative stress in patients with unstable angina. Eur Heart J. 15:1994;179-183.
9. Frijns C.J., Kappelle L.J., van Gijn J., et al. Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis. Stroke. 28:1997;2214-2218.
10. Hwang S.J., Ballantyne C.M., Sharrett A.R., et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation. 96:1997;4219-4225.
11. Wallen N.H., Held C., Rehnqvist N. et al., Elevated serum intercellular adhesion molecule-1 and vascular adhesion molecule-1 among patients with stable angina pectoris who suffer cardiovascular death or non-fatal myocardial infarction. Eur Heart J. 20:1999;1039-1043.
12. de Lemos J.A., Hennekens C.H., Ridker P.M. Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk. J Am Coll Cardiol. 36:2000;423-426.
13. O'malley T., Ludlam C.A., Riemermsa R.A., et al. Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1). Potential risk factor for the acute coronary syndromes. Eur Heart J. 22:2001;1226-1234.
14. Paolisso G., Esposito R., D'Alessio M.A., et al. Primary and secondary prevention of atherosclerosis: is there a role for antioxidants? Diabetes Metab. 25:1999;298-306.
15. Tardif J.C., Cote G., Lesperance J., et al. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group. New Engl J Med. 337:1997;365-372.
16. Mercuri F., Quagliaro L., Ceriello A. Oxidative stress evaluation in diabetes. Diabetes Technol Ther. 2:2000;589-600.
17. Feillet-Coudray C., Tourtauchaux R., Niculescu M., et al. Plasma levels of 8-epiPGF2alpha, an in vivo marker of oxidative stress, are not affected by aging or Alzheimer's disease. Free Radic Biol Med. 27:1999;463-469.
18. Ionescu J.G., Merk M., Bradford R. Redox and free radical monitoring in the clinical practice. J Integrative Med. 1:1999;73-75.
19. Davies B., Edwards S.W. Chemiluminescence of human bloodstream monocytes and neutrophils: an unusal oxidant(s) generated by monocytes during the respiratory burst. J Bioluminesc Chemiluminesc. 7:1992;229-238.
20. Radice M., Giudici V., Albertini A., et al. Similarity of electrocardiographic ischemia in syndrome X and in coronary artery disease. Am J Cardiol. 73:1994;968-969.
21. Cannon R.O., Epstein S.E. Microvascular angina as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol. 61:1988;1338-1343.
22. Chen J.W., Ting C.T., Chen C.I., et al. Coronary microvascular dysfunction is associated with ischemic-like electrocardiogram during exercise in patients with anginal chest pain and normal coronary angiograms. Jpn Heart J. 37:1996;865-878.
23. Desideri G., Gaspardone A., Gentile M., et al. Endothelial activation in patients with cardiac syndrome X. Circulation. 102:2000;2359-2364.
24. Siminiak T., Smielecki J., Rzezniczak J., et al. The effects of dipyridamole stress test on plasma levels of soluble adhesion molecules intracellular adhesion molecule-1, vascular cell adhesion molecule-1, E-selectin and L-selectin in patients with ischemic heart disease and patients with syndrome X. Coron Artery Dis. 10:1999;235-240.
25. Tousoulis D., Davies G.J., Asimakopoulos G., et al. Vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 serum level in patients with chest pain and normal coronary arteries (syndrome X). Clin Cardiol. 24:2001;301-304.
26. Chen J.W., Lee W.L., Hsu N.W., et al. Effects of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina. Am J Cardiol. 80:1997;32-38.
27. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultra centrifuge. Clin Chem. 18:1972;499-502.
28. Liu T.Z., Tsai C.H. Generation of superoxide radicals by human serum containing methylglyoxal: a mechanistic interpretation. J Biomed Lab Sci. 12:2000;62-64.
29. Tsai C.H., Chern C.L., Liu T.Z. Antioxidant action of glutathione: its interaction with superoxide anion, and hydroxyl radicals. J Biomed Lab Sci. 12:2000;107-111.
30. Balbay Y., Tikiz H., Baptiste R.J., et al. Circulating interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha, and soluble ICAM-1 in patients with chronic stable angina and myocardial infarction. Angiology. 52:2001;109-114.
31. Semaan H.B., Gurbel P.A., Anderson J.L., et al. Soluble VCAM-1 and E-selectin, but not ICAM-1 discriminate endothelial injury in patients with documented coronary artery disease. Cardiology. 93:2000;7-10.
32. Leatham E.W., Bath P.M., Tooze J.A., Camm A.J. Increased monocyte tissue factor expression in coronary disease. Br Heart J. 73:1995;10-13.
33. Storz G., Imlay J.A. Oxidative stress. Curr Opin Microbiol. 2:1999;188-194.
34. Wallen N.H., Held C., Rehnqvist N., Hjemdahl P. Elevated serum intercellular adhesion molecule-1 and vascular adhesion molecule-1 among patients with stable angina pectoris who suffer cardiovascular death or non-fatal myocardial infarction. Eur Heart J. 20:1999;1039-1043.
35. Iiyama K., Hajra L., Iiyama M., Li H., DiChiara M., Medoff B.D., Cybulsky M.I. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res. 85:1999;199-207.
36. Huo Y., Ley K. Adhesion molecules and atherogenesis. Acta Physiol Scand. 173:2001;35-43.
37. Sanderson J.E., Woo K.S., Chung H.K., et al. Endothelium-dependent dilation of the coronary arteries in syndrome X: effects of the cold pressure test. Cardiology. 88:1997;414-417.
38. Bellamy M.F., Goodfellow J., Tweddel A.C., et al. Syndrome X and endothelial dysfunction. Cardiovasc Res. 40:1998;410-417.
39. Tselepis A.D., Elisaf M., Goudevenos J., et al. Lipid profile in patients with microvascular angina. Eur J Clin Invest. 26:1996;1150-1155.
40. Watson A.D., Berliner J.A., Hama S.Y., et al. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low-density lipoprotein. J Clin Invest. 96:1995;2882-2891.
41. Cockerill G.W., Rye K.A., Gamble J.R., et al. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol. 15:1995;1987-1994.
42. Cockerill G.W., Rye K.A., Gamble J.R., et al. High-density lipoproteins differentially modulate cytokine-induced expression of E-selectin and cyclooxygenase-2. Arterioscler Thromb Vasc Biol. 19:1999;910-917.
43. Petzke K.J., Elsner A., Proll J., Thielecke F., Metges C.C. Long-term high protein intake does not increase oxidative stress in rats. J Nutr. 130:2000;2889-2896.
44. Matsumoto K., Miyake S., Yano M., et al. High serum concentrations of soluble E-selectin in patients with impaired glucose tolerance with hyperinsulinemia. Atherosclerosis. 152:2000;415-420.
45. Kaski J.C., Rosano G.C., Collins P., et al. Cardiac syndrome X: clinical characteristics and left ventricular function-long term follow-up study. J Am Coll Cardiol. 25:1995;807-814.
46. Litchtlen P.R., Bargheer K., Wenzlaff P. Long-term prognosis of patients with angina-like chest pain and normal coronary angiographic findings. J Am Coll Cardiol. 25:1995;1013-1018.
47. Seljeflot I., Tonstad S., Hjermann I., Arnesen H. Reduced expression of endothelial cell markers after 1 year treatment with simvastatin and atorvastatin in patients with coronary heart disease. Atherosclerosis. 162:2002;179-185.